121 related articles for article (PubMed ID: 18941013)
1. Bevacizumab-based therapy for advanced small bowel adenocarcinoma.
Tsang H; Yau T; Khong PL; Epstein RJ
Gut; 2008 Nov; 57(11):1631-2. PubMed ID: 18941013
[No Abstract] [Full Text] [Related]
2. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
Grothey A; Ellis LM
Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
[TBL] [Abstract][Full Text] [Related]
3. Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma.
Grover S; Gupta S; Sharma R; Brar VS; Chalam KV
Br J Ophthalmol; 2009 Feb; 93(2):273-4. PubMed ID: 18617542
[No Abstract] [Full Text] [Related]
4. Body fatness and bevacizumab-based therapy in metastatic colorectal cancer.
Renehan AG
Gut; 2010 Mar; 59(3):289-90. PubMed ID: 20207633
[No Abstract] [Full Text] [Related]
5. The effect of intravitreal bevacizumab treatment on choroidal metastasis of colon adenocarcinoma--case report.
Lin CJ; Li KH; Hwang JF; Chen SN
Eye (Lond); 2010 Jun; 24(6):1102-3. PubMed ID: 19893587
[No Abstract] [Full Text] [Related]
6. Anti-vascular endothelial growth factor agents for pediatric retinal diseases.
Wykoff CC; Houston SK; Berrocal AM
Int Ophthalmol Clin; 2011; 51(1):185-99. PubMed ID: 21139484
[No Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab for vitreous haemorrhage.
Jonas JB; Libondi T; von Baltz S; Vossmerbaeumer U
Acta Ophthalmol; 2008 Aug; 86(5):585-6. PubMed ID: 18081904
[No Abstract] [Full Text] [Related]
8. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
Willett CG; Boucher Y; di Tomaso E; Duda DG; Munn LL; Tong RT; Chung DC; Sahani DV; Kalva SP; Kozin SV; Mino M; Cohen KS; Scadden DT; Hartford AC; Fischman AJ; Clark JW; Ryan DP; Zhu AX; Blaszkowsky LS; Chen HX; Shellito PC; Lauwers GY; Jain RK
Nat Med; 2004 Feb; 10(2):145-7. PubMed ID: 14745444
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
[TBL] [Abstract][Full Text] [Related]
10. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
11. Bevacizumab: one treatment for all the seasons?
Gelibter AJ; Di Segni S; Zeuli M; Cognetti F
J Clin Oncol; 2008 Jan; 26(3):511; author reply 511-2. PubMed ID: 18202430
[No Abstract] [Full Text] [Related]
12. Hormone-refractory prostate cancer responding to bevacizumab.
Iacobelli S
Int J Urol; 2008 Aug; 15(8):754. PubMed ID: 18786200
[No Abstract] [Full Text] [Related]
13. Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.
Thornton AD; Ravn P; Winslet M; Chester K
Br J Surg; 2006 Dec; 93(12):1456-63. PubMed ID: 17115389
[TBL] [Abstract][Full Text] [Related]
14. More on bevacizumab in hereditary hemorrhagic telangiectasia.
Retornaz F; Rinaldi Y; Duvoux C
N Engl J Med; 2009 Aug; 361(9):931; author reply 931-2. PubMed ID: 19714790
[No Abstract] [Full Text] [Related]
15. [New medications; bevacizumab].
Cohen AF; van Bronswijk H
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy.
Lee JY; Chae JB; Yang SJ; Kim JG; Yoon YH
Acta Ophthalmol; 2011 May; 89(3):e293-4. PubMed ID: 20346078
[No Abstract] [Full Text] [Related]
17. The role of bevacizumab in hearing preservation and tumor volume control in patients with vestibular schwannomas.
Komotar RJ; Starke RM; Sisti MB; Connolly ES
Neurosurgery; 2009 Dec; 65(6):N12. PubMed ID: 19934951
[No Abstract] [Full Text] [Related]
18. [PZ Innovation Prize for Avastin: Bevacizumab--new therapy option in colon carcinoma].
Krankenpfl J; 2005; 43(7-10):234. PubMed ID: 16515304
[No Abstract] [Full Text] [Related]
19. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
Laud K; Spaide RF; Freund KB; Slakter J; Klancnik JM
Retina; 2006 Oct; 26(8):960-3. PubMed ID: 17031300
[No Abstract] [Full Text] [Related]
20. Bronchoscopy for bevacizumab-related hemoptysis.
Cho YJ; Murgu SD; Colt HG
Lung Cancer; 2007 Jun; 56(3):465-8. PubMed ID: 17368626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
